NEW YORK (GenomeWeb) – Natera today announced that its cloud-based software has received CE marking, allowing the company to market the product in the European Union and other countries that accept the designation.

The software supports multiple applications, including Natera's Panorama non-invasive prenatal test, and delivers the company's analytical services to its laboratory customers in a manner that is highly secure as well as easy to integrate and scale, Natera said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.